Search company, investor...


Founded Year



Acquired | Acquired

Total Raised




About NanoMR

nanoMR has developed a system for rapid isolation of rare cells from complex matrices at levels of 1 cell/mL or lower. The immunomagnetic capture system can target multiple cell types simultaneously, for example capturing bacteria and fungi from bloodstream infections, or specific cell types, such as circulating tumor, or fetal, cells, in less than 30 minutes. nanoMR's first product will address the blood culture market. The Pathogen Capture System recovers microbial cells directly from blood drawn into a standard Green-Topped Vacutainer tube and delivers purified microbial DNA in approximately 50 minutes. Analysis by conventional methods, such as PCR, permits identification of the causative agent(s) in less than two hours, allowing physicians to initiate appropriate therapy shortly after presentation of a suspected bloodstream infection.

Headquarters Location

5741 Midway Park Blvd.

Albuquerque, New Mexico, 87109,

United States


Missing: NanoMR's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: NanoMR's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing NanoMR

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

NanoMR is included in 5 Expert Collections, including Medical Devices.


Medical Devices

8,633 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.



1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data


Digital Health

10,347 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.


Health IT

7,901 items

NanoMR Patents

NanoMR has filed 15 patents.

patents chart

Application Date

Grant Date


Related Topics




Molecular biology, Genetics, Biotechnology, DNA, Immune system


Application Date


Grant Date



Related Topics

Molecular biology, Genetics, Biotechnology, DNA, Immune system



Latest NanoMR News

DNAe Moves NanoMR To California

Dec 7, 2015

In a blow to Albuquerque's local life sciences industry, DNAe , a UK-based developer of semiconductor-based DNA sequencing technology, said Friday that it is moving its entire operation in the city to California. DNAe's operations in Albuquerque are the result of its acquisition in January of NanoMR , which was incubated and spun out of the University of New Mexico. DNAe said it has offered relocation to the entire staff of NanoMR to San Diego, California, where the company hopes to increase the size of its workforce and ramp its commercial efforts. DNAe said it would continue to work with the University of New Mexico on future efforts.

NanoMR Frequently Asked Questions (FAQ)

  • When was NanoMR founded?

    NanoMR was founded in 2006.

  • Where is NanoMR's headquarters?

    NanoMR's headquarters is located at 5741 Midway Park Blvd., Albuquerque.

  • What is NanoMR's latest funding round?

    NanoMR's latest funding round is Acquired.

  • How much did NanoMR raise?

    NanoMR raised a total of $25.52M.

  • Who are the investors of NanoMR?

    Investors of NanoMR include DNAe, Sun Mountain Capital, Excel Venture Management, Sanderling Ventures, Signal Peak Ventures and 4 more.

  • Who are NanoMR's competitors?

    Competitors of NanoMR include Seno Medical Instruments, Integrated Diagnostics, Daktari Diagnostics, LipoScience, Adlyfe and 11 more.

Compare NanoMR to Competitors

MC Laboratory

People today suffer from stress and disturbed eating habits which can increase wastes in blood and cause interrupted blood flow. MC FAN is a blood fluidity measurement device (blood fluidity analyzer) which simulates capillary vessels. When a blood sample is applied to the analyzer, the condition of the blood can be displayed on the TV monitor in real time.

Cellpoint Diagnostics

CellPoint Diagnostics is developing diagnostic, monitoring, and molecular analytical tools for cancer. Its technology captures and analyzes circulating tumor cells ("CTCs") directly from patient blood. Scientific and clinical data have demonstrated that CTCs are derived from the primary tumor, and the assessment of the number of CTCs in the blood has been shown to accurately predict survival for cancer patients.

Nanogen Adavanced Diagnostics S.r.l.

At Nanogen, Inc., the company develop diagnostic products that enable physicians to deliver improved patient care. The company's products allow faster and easier diagnosis, treatment and monitoring of cardiovascular disease and infectious diseases. These products include molecular diagnostic kits and reagents, and rapid test kits, which can be used in urgent care settings or at the point-of-care. Nanogen has pioneered developments in areas involving biomarkers, molecular biology and nanotechnology. The company's business focus is to bring better results to diagnostics and healthcare.

Debiotech SA

Debiotech is their partner for the development of medical devices for therapeutic and diagnostic purposes :nDisposable programmable micropumps, miniaturized infusion pumps, contrast media injectors, drug reconstitution devices, cycler for peritoneal dialysis, flow regulators, nano delivery systems...


AiMedics is an Australian company developing a device for non-invasive measurement of nocturnal hypoglycaemia (low blood sugar) for Type 1 juvenile diabetes from UTS, Sydney.

Capsulution NanoScience AG

Capsulution Nanoscience AG are developers of advanced drug delivery carriers, medical devices and diagnostic particles.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.